Works matching IS 10837159 AND DT 2015 AND VI 20 AND IP 3

Results: 20

Challenges of Efficacy Assessments in Pseudomyxoma Peritonea.

Published in:

2015

By:

Overman, Michael J.;
Eng, Cathy;
Raghav, Kanwal;
Matamoros, Aurelio;
Taggart, Melissa;
Wai Chin Foo;
Fournier, Keith

Publication type:

Journal Article

Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 243, doi. 10.1634/theoncologist.2014-0400

By:

Wang‐Lopez, Qian;
Mouret‐Reynier, Marie‐Ange;
Savoye, Aude‐Marie;
Abrial, Catherine;
Kwiatkowski, Fabrice;
Garbar, Christian;
DuBray‐Longeras, Pascale;
Eymard, Jean‐Christophe;
Lebouedec, Guillaume;
Vanpraagh, Isabelle;
Penault‐Llorca, Frederique;
Chollet, Philippe;
Cure, Hervé

Publication type:

Article

TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients With Urothelial Bladder Cancer.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 263, doi. 10.1634/theoncologist.2014-0391

By:

Wang, Kun;
Liu, Tiantian;
Liu, Cheng;
Meng, Yan;
Yuan, Xiaotian;
Liu, Li;
Ge, Nan;
Liu, Jikai;
Wang, Chang;
Ren, Hongbo;
Yan, Keqiang;
Hu, Sanyuan;
Xu, Zhonghua;
Fan, Yidong;
Xu, Dawei

Publication type:

Article

Phase I Study of Cisplatin, Hyperthermia, and Lapatinib in Patients With Recurrent Carcinoma of the Uterine Cervix in a Previously Irradiated Area.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 241, doi. 10.1634/theoncologist.2014-0365

By:

Meerten, Esther;
Franckena, Martine;
Wiemer, Erik;
Doorn, Lena;
Kraan, Jaco;
Westermann, Anneke;
Sleijfer, Stefan

Publication type:

Article

Helical Tomotherapy in Head and Neck Cancer: A European Single-Center Experience.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 279, doi. 10.1634/theoncologist.2014-0337

By:

Van Gestel, Dirk;
Van den Weyngaert, Danielle;
De Kerf, Geert;
De Ost, Bie;
Vanderveken, Olivier;
Van Laer, Carl;
Specenier, Pol;
Geussens, Yasmyne;
Wouters, Kristien;
Meulemans, Els;
Cheung, Kin Jip;
Grégoire, Vincent;
Vermorken, Jan B.

Publication type:

Article

Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147), a Pan-Class I PI3K Inhibitor, in CombinationWith Erlotinib in Patients With Solid Tumors.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 245, doi. 10.1634/theoncologist.2014-0449

By:

Soria, Jean‐Charles;
LoRusso, Patricia;
Bahleda, Ratislav;
Lager, Joanne;
Liu, Li;
Jiang, Jason;
Martini, Jean‐François;
Macé, Sandrine;
Burris, Howard

Publication type:

Article

M1 Stage Subdivision and Treatment Outcome of Patients With Bone-Only Metastasis of Nasopharyngeal Carcinoma.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 291, doi. 10.1634/theoncologist.2014-0206

By:

Shen, Lujun;
Dong, Jun;
Li, Sheng;
Wang, Yue;
Dong, Annan;
Shu, Wanhong;
Wu, Ming;
Pan, Changchuan;
Xia, Yunfei;
Wu, Peihong

Publication type:

Article

A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 239, doi. 10.1634/theoncologist.2014-0326

By:

Pietri, Elisabetta;
Andreis, Daniele;
Fabbri, Francesca;
Menna, Cecilia;
Schirone, Alessio;
Kopf, Barbara;
Rocca, Andrea;
Amadori, Dino;
De Giorgi, Ugo

Publication type:

Article

Progestins in the Fertility-Sparing Treatment and Retreatment of Patients With Primary and Recurrent Endometrial Cancer.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 270, doi. 10.1634/theoncologist.2013-0445

By:

Park, Jeong‐Yeol;
Nam, Joo‐Hyun

Publication type:

Article

Should FOLFOXIRI Plus Bevacizumab Be the Standard First-Line Therapy inMetastatic Colorectal Cancer?

Published in:

Oncologist, 2015, v. 20, n. 3, p. 236, doi. 10.1634/theoncologist.2014-0495

By:

Nipp, Ryan D.;
Ryan, David P.

Publication type:

Article

Immunohistochemical Validation of Overexpressed Genes Identified by Global ExpressionMicroarrays in Adrenocortical Carcinoma Reveals Potential Predictive and Prognostic Biomarkers.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 247, doi. 10.1634/theoncologist.2014-0392

By:

Ip, Julian C.Y.;
Pang, Tony C.Y.;
Glover, Anthony R.;
Soon, Patsy;
Zhao, Jing Ting;
Clarke, Stephen;
Robinson, Bruce G.;
Gill, Anthony J.;
Sidhu, Stan B.

Publication type:

Article

The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials

Published in:

Oncologist, 2015, v. 20, n. 3, p. 307, doi. 10.1634/theoncologist.2014-0285

By:

Hasegawa, Yoshikazu;
Ando, Masahiko;
Maemondo, Makoto;
Yamamoto, Satomi;
Isa, Shun‐ichi;
Saka, Hideo;
Kubo, Akihito;
Kawaguchi, Tomoya;
Takada, Minoru;
Rosell, Rafael;
Kurata, Takayasu;
Ou, Sai‐Hong Ignatius

Publication type:

Article

The European Medicines Agency Review of Pomalidomide in CombinationWith Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee forMedicinal Products for Human Use.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 329, doi. 10.1634/theoncologist.2014-0073

By:

Hanaizi, Zahra;
Flores, Beatriz;
Hemmings, Robert;
Camarero, Jorge;
Sancho‐Lopez, Arantxa;
Salmonson, Tomas;
Gisselbrecht, Christian;
Laane, Edward;
Pignatti, Francesco

Publication type:

Article

Complex Decisions for First-Line and Maintenance Treatment of Advanced Wild-Type Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 299, doi. 10.1634/theoncologist.2014-0212

By:

Gentzler, Ryan D.;
Johnson, Melissa L.

Publication type:

Article

Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 323, doi. 10.1634/theoncologist.2014-0420

By:

Carlo‐Stella, Carmelo;
Ricci, Francesca;
Dalto, Serena;
Mazza, Rita;
Malagola, Michele;
Patriarca, Francesca;
Viviani, Simonetta;
Russo, Domenico;
Giordano, Laura;
Castagna, Luca;
Corradini, Paolo;
Santoro, Armando

Publication type:

Article

In Reply.

Published in:

Oncologist, 2015, v. 20, n. 3, p. e5, doi. 10.1634/theoncologist.2014-423

By:

Baratti, Dario;
Kusamura, Shigeki;
Maggi, Claudia;
Braud, Filippo;
Deraco, Marcello;
Di Bartolomeo, Maria;
Pietrantonio, Filippo

Publication type:

Article

Prostate-Specific Antigen Testing: Good or Bad?

Published in:

Oncologist, 2015, v. 20, n. 3, p. 233, doi. 10.1634/theoncologist.2015-0019

By:

Albertsen, Peter C.

Publication type:

Article

Challenges of Efficacy Assessments in Pseudomyxoma Peritonea.

Published in:

2015

By:

Overman, Michael J.;
Eng, Cathy;
Raghav, Kanwal;
Matamoros, Aurelio;
Taggart, Melissa;
Foo, Wai Chin;
Fournier, Keith

Publication type:

Letter to the Editor

Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 316, doi. 10.1634/theoncologist.2014-0389

By:

Pekar‐Zlotin, Marina;
Hirsch, Fred R.;
Soussan‐Gutman, Lior;
Ilouze, Maya;
Dvir, Addie;
Boyle, Theresa;
Wynes, Murry;
Miller, Vincent A.;
Lipson, Doron;
Palmer, Gary A.;
Ali, Siraj M.;
Dekel, Shlomi;
Brenner, Ronen;
Bunn, Paul A.;
Peled, Nir

Publication type:

Article

External Quality Assessment Unravels Interlaboratory Differences in Quality of RAS Testing for Anti-EGFR Therapy in Colorectal Cancer.

Published in:

Oncologist, 2015, v. 20, n. 3, p. 257, doi. 10.1634/theoncologist.2014-0382

By:

Tack, Véronique;
Ligtenberg, Marjolijn J.L.;
Tembuyser, Lien;
Normanno, Nicola;
Vander Borght, Sara;
Han van Krieken, J.;
Dequeker, Elisabeth M.C.

Publication type:

Article